South Korea · Delayed Price · Currency is KRW SG HealthCare Statistics
Total Valuation
SG HealthCare has a market cap or net worth of KRW 436.78 billion. The enterprise value is 443.68 billion.
| Market Cap | 436.78B |
| Enterprise Value | 443.68B |
Important Dates
The next estimated earnings date is Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SG HealthCare has 108.52 million shares outstanding. The number of shares has increased by 19.77% in one year.
| Current Share Class | 108.52M |
| Shares Outstanding | 108.52M |
| Shares Change (YoY) | +19.77% |
| Shares Change (QoQ) | +4.30% |
| Owned by Insiders (%) | 3.16% |
| Owned by Institutions (%) | 0.84% |
| Float | 104.83M |
Valuation Ratios
The trailing PE ratio is 47.35.
| PE Ratio | 47.35 |
| Forward PE | n/a |
| PS Ratio | 17.75 |
| PB Ratio | 17.94 |
| P/TBV Ratio | 19.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 210.59, with an EV/FCF ratio of -74.75.
| EV / Earnings | 474.21 |
| EV / Sales | 18.03 |
| EV / EBITDA | 210.59 |
| EV / EBIT | n/a |
| EV / FCF | -74.75 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.74 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 4.19 |
| Debt / FCF | -1.49 |
| Interest Coverage | 3.81 |
Financial Efficiency
Return on equity (ROE) is 3.97% and return on invested capital (ROIC) is 4.48%.
| Return on Equity (ROE) | 3.97% |
| Return on Assets (ROA) | 2.50% |
| Return on Invested Capital (ROIC) | 4.48% |
| Return on Capital Employed (ROCE) | 5.86% |
| Weighted Average Cost of Capital (WACC) | 5.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.28 |
Taxes
In the past 12 months, SG HealthCare has paid 102.26 million in taxes.
| Income Tax | 102.26M |
| Effective Tax Rate | 9.86% |
Stock Price Statistics
The stock price has increased by +52.11% in the last 52 weeks. The beta is 0.17, so SG HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +52.11% |
| 50-Day Moving Average | 3,961.80 |
| 200-Day Moving Average | 3,323.18 |
| Relative Strength Index (RSI) | 49.46 |
| Average Volume (20 Days) | 171,774 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SG HealthCare had revenue of KRW 24.60 billion and earned 935.60 million in profits. Earnings per share was 85.00.
| Revenue | 24.60B |
| Gross Profit | 7.08B |
| Operating Income | 1.47B |
| Pretax Income | 1.04B |
| Net Income | 935.60M |
| EBITDA | 2.11B |
| EBIT | 1.47B |
| Earnings Per Share (EPS) | 85.00 |
Balance Sheet
The company has 2.36 billion in cash and 8.84 billion in debt, with a net cash position of -6.47 billion or -59.66 per share.
| Cash & Cash Equivalents | 2.36B |
| Total Debt | 8.84B |
| Net Cash | -6.47B |
| Net Cash Per Share | -59.66 |
| Equity (Book Value) | 24.35B |
| Book Value Per Share | 2,186.94 |
| Working Capital | 11.48B |
Cash Flow
In the last 12 months, operating cash flow was -4.24 billion and capital expenditures -1.70 billion, giving a free cash flow of -5.94 billion.
| Operating Cash Flow | -4.24B |
| Capital Expenditures | -1.70B |
| Depreciation & Amortization | 639.51M |
| Net Borrowing | 1.42B |
| Free Cash Flow | -5.94B |
| FCF Per Share | -54.70 |
Margins
Gross margin is 28.80%, with operating and profit margins of 5.96% and 3.80%.
| Gross Margin | 28.80% |
| Operating Margin | 5.96% |
| Pretax Margin | 4.22% |
| Profit Margin | 3.80% |
| EBITDA Margin | 8.56% |
| EBIT Margin | 5.96% |
| FCF Margin | n/a |
Dividends & Yields
SG HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.77% |
| Shareholder Yield | -19.77% |
| Earnings Yield | 0.21% |
| FCF Yield | -1.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.3285691.
| Last Split Date | Dec 4, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.3285691 |
Scores
SG HealthCare has an Altman Z-Score of 2.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.27 |
| Piotroski F-Score | 3 |